The Power of Genome Editing: What Investors Should Know

The cost of sequencing a human genome has dropped significantly over the past years and genome editing is enabling new breakthroughs in medicine. On the upcoming webcast, The Power of Genome Editing: What Investors Should Know, Manisha Samy, Analyst Genomic Revolution at ARK Invest, and Renato...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.